- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cytek Biosciences Inc (CTKB)
Cytek Biosciences Inc stock price live, this page displays NASDAQ CTKB stock exchange data. View the CTKB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cytek Biosciences Inc real time stock price chart below.
What Is the Cytek Biosciences Inc Stock Price Today?
The Cytek Biosciences Inc stock price today is 3.87.
What Is the Stock Symbol for Cytek Biosciences Inc?
The stock symbol for Cytek Biosciences Inc is ""CTKB.""
What Stock Exchange Does Cytek Biosciences Inc Trade On?
Cytek Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Cytek Biosciences Inc a Good Stock to Buy?
Determining whether Cytek Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTKB quote. (ISIN: US23285D1090)
What Is the Cytek Biosciences Inc Stock Price Today?
The Cytek Biosciences Inc stock price today is 3.87.
What Is the Stock Symbol for Cytek Biosciences Inc?
The stock symbol for Cytek Biosciences Inc is ""CTKB.""
What Stock Exchange Does Cytek Biosciences Inc Trade On?
Cytek Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Cytek Biosciences Inc a Good Stock to Buy?
Determining whether Cytek Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTKB quote. (ISIN: US23285D1090)
3.87
+0.03(+0.78%)
Real-time Data·
Fair Value
An estimate of a Cytek Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.80
3.88
52 wk Range
2.37
7.63
CTKB Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected tomorrow
More Info
Fair Value
An estimate of a Cytek Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.803.88
52 wk Range
2.377.63
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CTKB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cytek Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
5.75
Upside
+48.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Cytek Biosciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Cytek Biosciences Inc For: 24 June
- Investing.com
- Form 8K Cytek Biosciences Inc For: 24 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Cytek Biosciences Inc Company Profile
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Cytek Biosciences Inc Earnings Call Summary for Q1/2025
- Cytek Biosciences reported Q1 2025 EPS of -$0.09, missing -$0.02 forecast; revenue fell 7.6% YoY to $41.5M, below $43.82M estimate
- Product revenue declined 18% YoY, while service revenue grew 24%; GAAP net loss widened to $11.4M from $6.2M in Q1 2024
- Company maintained full-year 2025 revenue guidance of $196-210M, expecting stronger growth in H2; stock remained stable at $3.79
- CEO highlighted leadership in cell analysis market; CFO noted over 50% of revenue from international markets
- Challenges include declining product revenue, increased net loss, and potential 1-3% tariff impact on gross margins
Last Updated: 08/05/2025, 22:30
Read Full TranscriptCompare CTKB to Peers and Sector
Metrics to compare | CTKB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCTKBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −43.2x | −2.9x | −0.5x | |
PEG Ratio | - | −0.13 | 0.00 | |
Price/Book | 1.3x | 1.1x | 2.6x | |
Price / LTM Sales | 2.5x | 1.6x | 3.3x | |
Upside (Analyst Target) | 43.2% | 55.2% | 43.5% | |
Fair Value Upside | Unlock | 27.3% | 6.3% | Unlock |
Analyst Ratings
2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.75
(+48.58% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.09 / -0.02
Revenue / Forecast
41.50M / 43.82M
People Also Watch
FAQ
What Stock Exchange Does Cytek Biosciences Trade On?
Cytek Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Cytek Biosciences?
The stock symbol for Cytek Biosciences is "CTKB."
What Is the Cytek Biosciences Market Cap?
As of today, Cytek Biosciences market cap is 490.17M.
What Is Cytek Biosciences's Earnings Per Share (TTM)?
The Cytek Biosciences EPS (TTM) is -0.09.
When Is the Next Cytek Biosciences Earnings Date?
Cytek Biosciences will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is CTKB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cytek Biosciences Stock Split?
Cytek Biosciences has split 0 times.
How Many Employees Does Cytek Biosciences Have?
Cytek Biosciences has 663 employees.
What is the current trading status of Cytek Biosciences (CTKB)?
As of 05 Aug 2025, Cytek Biosciences (CTKB) is trading at a price of 3.87, with a previous close of 3.84. The stock has fluctuated within a day range of 3.80 to 3.88, while its 52-week range spans from 2.37 to 7.63.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.